risk of pancreatitis with semaglutide RACGP Pancreatitis Risk Associated with GLP-1

Semaglutide: The GLP-1 Agonist Semaglutide, the active ingredient in medications like Wegovy (for weight management) and Ozempic (primarily for type 2 diabetes), is a potent agonist of the glucagon-like peptide-1 (GLP-1) receptor

COVID-19 and long COVID: disruption of the neurovascular unit, blood-brain barrier, and tight junctions

It mimics a hormone called glucagon-like peptide-1 (GLP-1), which regulates appetite and food intake

Altered Metabolism of Bile Acids Correlates With Clinical Parameters and the Gut Microbiota in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Saccharin and water intake was monitored for 24 h followed by preference determination

, '